Paricalcitol

Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.

Cross Reference

Introduction

To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Paricalcitol?

Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Paricalcitol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Paricalcitol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Paricalcitol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What genes are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Paricalcitol

Download all related citations
Per page 10 20 50 100 | Total 375
Authors Title Published Journal PubMed Link
Slatopolsky E et al. Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats. 2002 Kidney Int. pmid:12234297
Bailie GR and Johnson CA Comparative review of the pharmacokinetics of vitamin D analogues. 2002 Sep-Oct Semin Dial pmid:12358640
Coyne DW et al. Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients. 2002 Am. J. Kidney Dis. pmid:12460048
Molnár I et al. 19-nor-1alpha,25-dihydroxyvitamin D(2) (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines. 2003 J. Cancer Res. Clin. Oncol. pmid:12618899
Sprague SM et al. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. 2003 Kidney Int. pmid:12631365
Martin CJ and Reams SM The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey. 2003 J Ren Nutr pmid:12671837
Slatopolsky E et al. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia. 2003 Kidney Int. pmid:12753289
Cardús A et al. [Differential effect of vitamin D analogues on the proliferation of vascular smooth muscle cells]. 2003 Nefrologia pmid:12778867
Kumagai T et al. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells. 2003 J. Natl. Cancer Inst. pmid:12813173
Teng M et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. 2003 N. Engl. J. Med. pmid:12890843